Showing results (581-590 of 1,074) with videos related to
Sort By:
Pageof 108
The American Journal of Cardiology|August 3, 2012
Comparative one-year effectiveness of percutaneous coronary intervention versus coronary artery bypass grafting in patients <75 versus ≥75 years with unprotected left main disease (from the CUSTOMIZE Registry)Davide Capodanno, Anna Caggegi, Piera Capranzano, et al.European Heart Journal|December 7, 2020
Short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy vs. prolonged dual antiplatelet therapy after percutaneous coronary intervention with second-generation drug-eluting stents: a systematic review and meta-analysis of randomized clinical trialsDaniele Giacoppo, Yuji Matsuda, Luca Nai Fovino, et al.Journal of the American College of Cardiology|September 11, 2004
Intracoronary brachytherapy after stenting de novo lesions in diabetic patients: results of a randomized intravascular ultrasound studyManel Sabaté, Gela Pimentel, Carlos Prieto, et al.Seminars in Arthritis and Rheumatism|May 9, 2025
Direct oral anticoagulants versus Vitamin K antagonists in antiphospholipid syndrome: A systematic review and meta-analysisAlessandra Ida Celia, Giovanni Maria Vescovo, Gianmarco Sarto, et al.Journal of Thrombosis and Thrombolysis|September 18, 2013
Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patientsHenrik Wagner, Dominick J Angiolillo, Jurrien M Ten Berg, et al.Journal of the American College of Cardiology|September 19, 2006
Characterization of plaque prolapse after drug-eluting stent implantation in diabetic patients: a three-dimensional volumetric intravascular ultrasound outcome studyHideki Futamatsu, Manel Sabaté, Dominick J Angiolillo, et al.Circulation|February 15, 2015
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trialMatthew A Cavender, Benjamin M Scirica, Marc P Bonaca, et al.Circulation|June 17, 2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel studyMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.Circulation|October 6, 2005
Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trialManel Sabaté, Pilar Jiménez-Quevedo, Dominick J Angiolillo, et al.European Heart Journal|June 15, 2007
Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trialPilar Jiménez-Quevedo, Manel Sabaté, Dominick J Angiolillo, et al.Pageof 108